Omalizumab With Oral Food Immunotherapy With Food Allergies Open Label Safety Study in a Single Center
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The long-term goal of the investigators study is to develop a better and safer treatment for,
and to potentially cure patients with single or multiple food allergies. The investigators
hypothesize that the application of this protocol will allow patients with severe and single
or multiple food allergies to be safely and rapidly desensitized.